#sarcoma

[ follow ]
Cancer
fromTNW | Health-Tech
4 days ago

Cambridge biotech STORM Therapeutics raises $56M

STC-15 is the first RNA-modifying enzyme inhibitor in human trials, showing durable tumor regression in sarcoma subtypes during Phase 1.
#immunotherapy
fromwww.theguardian.com
8 months ago

Bad deaths scar families for ever': what terminally ill people want you to know about assisted dying

Maddie Cowey, diagnosed with incurable sarcoma at 18, manages her cancer through clinical trials. At 27, she's stable and prioritizing quality of life.
Public health
[ Load more ]